Status:

RECRUITING

Transurethral Modified En Bloc Resection For Large Bladder Tumours.

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Bladder Cancer

Bladder Neoplasm

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Modified en bloc resection is a hybrid technique involving piecemeal resection of the exophytic part of the bladder tumour, followed by en bloc resection of the tumour base. In this study, we shall in...

Detailed Description

The biggest limiting factor of en bloc resection is the size of the bladder tumour. Resection of the bladder tumour is technically feasible, but the retrieval of specimen in one piece is restricted by...

Eligibility Criteria

Inclusion

  • Age 18 to 80 years old with informed consent
  • Bladder tumours with maximal dimension of ≥ 3cm

Exclusion

  • Bladder tumour detected during intravesical Bacillus Calmette-Guerin therapy (These patients warrant more aggressive treatment, i.e. radical cystectomy)
  • Estimated glomerular filtration rate of \<60mL/min.
  • Presence of clinically significant cardiovascular disease (History of acute myocardial infarction, presence of uncontrolled angina within 3 months before screening, New York Heart Association Class III or IV congestive heart failure, presence of ventricular arrhythmias, or presence of second-degree or third-degree heart block)
  • Presence of GOLD Stage III or IV chronic obstructive pulmonary disease
  • History of bleeding disorder or use of anti-coagulant
  • Presence of other active malignancy
  • ECOG performance status ≥ 2 (Ambulatory and capable of all self care but unable to carry our any work activities. Confined to bed or chair less than 50% of waking hours)
  • Pregnancy
  • Presence of metallic foreign body or implant which is not MRI compatible
  • Known history of claustrophobia

Key Trial Info

Start Date :

September 7 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04081246

Start Date

September 7 2020

End Date

September 30 2024

Last Update

January 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prince of Wales Hospital

Hong Kong, Hong Kong